These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3627287)

  • 41. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".
    Paul SM; Rehavi M; Skolnick P; Ballenger JC; Goodwin FK
    Arch Gen Psychiatry; 1981 Dec; 38(12):1315-7. PubMed ID: 7316676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioural and electrocortical power spectrum effects of 5-methoxytryptoline and other analogs after intraventricular administration in rats.
    Nistico G; De Sarro GB; Langer SZ
    Eur J Pharmacol; 1987 Oct; 142(1):121-8. PubMed ID: 3691630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temperature-sensitive reversible loss of [3H]imipramine binding sites: evidence suggesting different conformational states.
    Dumbrille-Ross A; Morris J; Davis A; Tang SW
    Eur J Pharmacol; 1983 Aug; 91(4):383-9. PubMed ID: 6311587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of N-ethylmaleimide on 5-hydroxytryptamine transport and sodium content in rabbit platelets.
    Wölfel R; Halbrügge T; Graefe KH
    Br J Pharmacol; 1989 Aug; 97(4):1308-14. PubMed ID: 2790384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The serotonin transporter-imipramine "receptor".
    Talvenheimo J; Fishkes H; Nelson PJ; Rudnick G
    J Biol Chem; 1983 May; 258(10):6115-9. PubMed ID: 6853478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ligand binding to the serotonin transporter: equilibria, kinetics, and ion dependence.
    Humphreys CJ; Wall SC; Rudnick G
    Biochemistry; 1994 Aug; 33(31):9118-25. PubMed ID: 8049215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
    Plenge P; Mellerup ET
    Eur J Pharmacol; 1985 Dec; 119(1-2):1-8. PubMed ID: 2935414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
    Andersson A; Marcusson J
    Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solubilization of the platelet plasma membrane serotonin transporter in an active form.
    Talvenheimo J; Rudnick G
    J Biol Chem; 1980 Sep; 255(18):8606-11. PubMed ID: 7410380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antidepressant binding to the porcine and human platelet serotonin transporters.
    Humphreys CJ; Levin J; Rudnick G
    Mol Pharmacol; 1988 Jun; 33(6):657-63. PubMed ID: 3380080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nitroimipramines - synthesis and pharmacological effects of potent long-acting inhibitors of [3H] serotonin uptake and [3H] imipramine binding.
    Rehavi M; Ittah Y; Skolnick P; Rice KC; Paul SM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):45-9. PubMed ID: 7121610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-affinity binding of [3H]6-nitroquipazine to 5-hydroxytryptamine transporter in human platelets.
    Hashimoto K; Goromaru T
    Eur J Pharmacol; 1990 Oct; 187(3):295-302. PubMed ID: 2073917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification and properties of a human plasma endogenous modulator for the platelet tricyclic binding/serotonin transport complex.
    Abraham KI; Ieni JR; Meyerson LR
    Biochim Biophys Acta; 1987 Jan; 923(1):8-21. PubMed ID: 3542053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serotonin transport and storage in rabbit blood platelets--the effects of reserpine and imipramine.
    Reimers HJ; Allen DJ; Cazenave JP; Feuerstein IA; Mustard JF
    Biochem Pharmacol; 1977 Sep; 26(18):1645-55. PubMed ID: 901583
    [No Abstract]   [Full Text] [Related]  

  • 56. Circadian rhythm of the Bmax of [3H]-imipramine binding in rabbit platelets.
    Galzin AM; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):464-6. PubMed ID: 3431599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term verapamil treatment increases [3H]imipramine binding in human platelets.
    Cohen A; Weizman A; Eldar M; Rehavi M
    Eur J Pharmacol; 1990 Jun; 181(3):311-4. PubMed ID: 2166676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Demonstration of specific "high affinity" binding sites for [3H] imipramine on human platelets.
    Paul SM; Rehavi M; Skolnick P; Goodwin FK
    Life Sci; 1980 Mar; 26(12):953-9. PubMed ID: 6104760
    [No Abstract]   [Full Text] [Related]  

  • 59. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.